Current status of antiarrhythmic drug therapy.
D000779:Anesthetics, Local / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000628:therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000009:adverse effects; D004554:Electric Countershock; D006439:Hemodynamics / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000779:Anesthetics, Local; D000889:Anti-Arrhythmia Agents; D000927:Anticonvulsants; D000962:Antimalarials; D002395:Catecholamines; D004071:Digitalis Glycosides; D006634:Histamine H1 Antagonists; D013565:Sympatholytics; D014662:Vasoconstrictor Agents; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide